Lipitor and Zelboraf drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Zelboraf (vemurafenib). Common drug interactions include diarrhoea among females and rash among males.
The phase IV clinical study analyzes what interactions people have when they take Lipitor and Zelboraf. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.
What is Lipitor?
Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,048 Lipitor users. Check the latest studies of Lipitor.
What is Zelboraf?
Zelboraf has active ingredients of vemurafenib. eHealthMe is studying from 8,392 Zelboraf users. Check the latest studies of Zelboraf.
40 people who take Lipitor and Zelboraf together, and have interactions are studied.

What are the common drug interactions of Lipitor and Zelboraf, by gender? *:
female:
- Diarrhoea
- Dry skin
- Nausea (feeling of having an urge to vomit)
- Pruritus (severe itching of the skin)
- Death
- Arthropathy
- Asthenia (weakness)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Breast tenderness
- Cellulitis (infection under the skin)
male:
- Rash
- Sunburn
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Weight decreased
- Cardiac disorder
- Chest pain
- Drug effect decreased
- Lung infection
- Nausea (feeling of having an urge to vomit)
- Pneumonia
What are the common drug interactions of Lipitor and Zelboraf, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Death
- Depression
- Diarrhoea
- Drug effect decreased
- Eye pruritus (eye itching)
- Headache (pain in head)
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Hyperkeratosis (thickening of the outer layer of the skin)
- Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
- Ocular hyperaemia (an abnormally large amount of blood in eye)
60+:
- Rash
- Arthralgia (joint pain)
- Weight decreased
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Cardiac disorder
- Chest pain
- Lung infection
- Pneumonia
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Keratoacanthoma (a common low-grade (unlikely to metastasize or invade) skin tumour that is believed to originate from the neck of the hair follicle)
What are the existing conditions these people have? *
- Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 17 people, 42.50%
- Malignant Melanoma (skin cancer rises from melancytes): 16 people, 40.00%
- High Blood Pressure: 8 people, 20.00%
- Pain: 5 people, 12.50%
- Stress And Anxiety: 4 people, 10.00%
- Diabetes: 4 people, 10.00%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 7.50%
- Dyslipidaemia (abnormal amount of lipids): 3 people, 7.50%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.00%
- Heart Rate Increased: 2 people, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Lipitor and Zelboraf?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lipitor and Zelboraf:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lipitor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zelboraf:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lipitor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zelboraf and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
- Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
- Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on atorvastatin calcium and vemurafenib (the active ingredients of Lipitor and Zelboraf, respectively), and Lipitor and Zelboraf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zetia and Not Effective for Men aged 50-59 - 2 seconds ago
- Terminal State and drugs of ingredients of regorafenib - 2 seconds ago
- Zetia and Drug Ineffective for Men aged 50-59 - 3 seconds ago
- Drug interactions of Vitamin B6 and Aripiprazole - 10 seconds ago
- Tenormin vs. Plendil, side effect and effectiveness comparison - 19 seconds ago
- Drug interactions of Daunorubicin Hydrochloride and Methylprednisolone Sodium Succinate - 22 seconds ago
- Could Candesartan Cilexetil cause Vasculitis? - 25 seconds ago
- Drug interactions of Ginkgo and Coenzyme Q10 - 44 seconds ago
- Chronic Fatigue Syndrome in Mg, how severe and when it was recovered? - 49 seconds ago
- Lymphocyte Count Decreased and drugs of ingredients of adenosine - 53 seconds ago